Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Glia ; 72(7): 1273-1289, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38515286

RESUMEN

Tamoxifen-inducible systems are widely used in research to control Cre-mediated gene deletion in genetically modified animals. Beyond Cre activation, tamoxifen also exerts off-target effects, whose consequences are still poorly addressed. Here, we investigated the impact of tamoxifen on lipopolysaccharide (LPS)-induced neuroinflammatory responses, focusing on the neurogenic activity in the adult mouse dentate gyrus. We demonstrated that a four-day LPS treatment led to an increase in microglia, astrocytes and radial glial cells with concomitant reduction of newborn neurons. These effects were counteracted by a two-day tamoxifen pre-treatment. Through selective microglia depletion, we elucidated that both LPS and tamoxifen influenced astrogliogenesis via microglia mediated mechanisms, while the effects on neurogenesis persisted even in a microglia-depleted environment. Notably, changes in radial glial cells resulted from a combination of microglia-dependent and -independent mechanisms. Overall, our data reveal that tamoxifen treatment per se does not alter the balance between adult neurogenesis and astrogliogenesis but does modulate cellular responses to inflammatory stimuli exerting a protective role within the adult hippocampal neurogenic niche.


Asunto(s)
Hipocampo , Microglía , Neurogénesis , Tamoxifeno , Animales , Tamoxifeno/farmacología , Microglía/efectos de los fármacos , Microglía/metabolismo , Hipocampo/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Neurogénesis/fisiología , Ratones , Ratones Endogámicos C57BL , Lipopolisacáridos/farmacología , Enfermedades Neuroinflamatorias , Masculino , Ratones Transgénicos , Nicho de Células Madre/efectos de los fármacos , Nicho de Células Madre/fisiología
2.
Dis Model Mech ; 16(6)2023 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-37260288

RESUMEN

The nuclear receptor NR2F1 acts as a strong transcriptional regulator in embryonic and postnatal neural cells. In humans, mutations in the NR2F1 gene cause Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS), a rare neurodevelopmental disorder characterized by multiple clinical features including vision impairment, intellectual disability and autistic traits. In this study, we identified, by genome-wide and in silico analyses, a set of nuclear-encoded mitochondrial genes as potential genomic targets under direct NR2F1 transcriptional control in neurons. By combining mouse genetic, neuroanatomical and imaging approaches, we demonstrated that conditional NR2F1 loss of function within the adult mouse hippocampal neurogenic niche results in a reduced mitochondrial mass associated with mitochondrial fragmentation and downregulation of key mitochondrial proteins in newborn neurons, the genesis, survival and functional integration of which are impaired. Importantly, we also found dysregulation of several nuclear-encoded mitochondrial genes and downregulation of key mitochondrial proteins in the brain of Nr2f1-heterozygous mice, a validated BBSOAS model. Our data point to an active role for NR2F1 in the mitochondrial gene expression regulatory network in neurons and support the involvement of mitochondrial dysfunction in BBSOAS pathogenesis.


Asunto(s)
Factor de Transcripción COUP I , Anomalías del Ojo , Discapacidad Intelectual , Atrofia Óptica , Animales , Humanos , Ratones , Encéfalo/metabolismo , Factor de Transcripción COUP I/genética , Anomalías del Ojo/genética , Anomalías del Ojo/metabolismo , Discapacidad Intelectual/genética , Mitocondrias , Mutación/genética , Atrofia Óptica/genética , Atrofia Óptica/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...